PROM1 and infantile convulsions and choreoathetosis: However, there was a recent study by Cai et al. [49] demonstrating that the CD133+ non-mucin producing iCCA patients had significantly higher metastasis rate (36.7% vs. 10.1%) and shorter overall and disease-free survival time than CD133- patients.